CASP2 and Alzheimer disease: The protein levels of caspase 2 are significantly upregulated in AD brains, and it is a critical driver in synaptic dysfunction by activating the RhoA/ROCK-II signalling pathway, whereas reducing caspase 2 levels restores memory function [71,72,73].